SciSparc: AutoMax Announces $13 Million First Delivery of JAC Vehicles Following Regulatory Approval for Direct Importation
TEL AVIV, Israel, Dec. 26, 2024 (GLOBE NEWSWIRE) -- . (Nasdaq: SPRC) ("Company" or "SciSparc"), announced that AutoMax Motors ...
SciSparc Shares Skyrocket With AutoMax's First JAC Motors Shipment
SciSparc Ltd. (NASDAQ:SPRC) shares are rocketing on Thursday after it disclosed that AutoMax Motors Ltd., an Israeli ...
S&P 500 Edges Lower, SciSparc Shares Surge
U.S. stocks traded slightly lower toward the end of trading, with the S&P 500 edging lower on Thursday. The Dow traded down 0 ...
bovnews1d
What’s Behind SciSparc’s (SPRC) Jaw-Dropping Stock Spike Today?
This contrast underscores the volatility SciSparc has experienced, and yet the recent surge in its stock price shows that the market is reacting positively to recent developments, particularly in the ...
Business Insider2d
SciSparc Says AutoMax Receives First Delivery Of Vehicles From Jianghuai Automobile
(RTTNews) - SciSparc Ltd. (SPRC), a specialty clinical-stage pharma company, announced Thursday that AutoMax Motors Ltd. of Israel has received its first shipment of vehicles worth $13 million, ...
Business Insider1d
SciSparc Supports AutoMax’s $13 Million JAC Motors Vehicle Import
Discover the latest stocks recommended by top Wall Street analysts, all in one place with Analyst Top Stocks Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter ...
Nasdaq11d
SciSparc Ltd. Announces Amendment to LOI for Spin-Off of Pharmaceutical Assets Valued at Approximately $11.6 Million
SciSparc Ltd., a clinical-stage pharmaceutical company, announced an amendment to its non-binding letter of intent to spin off its pharmaceutical assets valued at approximately $11.6 million ...
Morningstar11d
SciSparc Provides Updates on Status of Spin-off of its Advanced Clinical Stage Pharmaceutical Portfolio to a Publicly Traded Company
Morningstar brands and products Company Portfolio ...
Mena FN12d
Scisparc Provides Updates On Status Of Spin-Off Of Its Advanced Clinical Stage Pharmaceutical Portfolio To A Publicly Traded Company
(MENAFN- GlobeNewsWire - Nasdaq) According to the LOI, SciSparc's pharmaceuticals assets are valued at approximately US$11.6 million TEL AVIV, Israel, Dec. 16, 2024 (GLOBE NEWSWIRE) -- SciSparc ...
Yahoo Finance12d
SciSparc Provides Updates on Status of Spin-off of its Advanced Clinical Stage Pharmaceutical Portfolio to a Publicly Traded Company
TEL AVIV, Israel, Dec. 16, 2024 (GLOBE NEWSWIRE) -- SciSparc Ltd. (Nasdaq: SPRC) (“Company” or “SciSparc”), a specialty clinical-stage pharmaceutical company focusing on the development of therapies ...
Benzinga.com19h
SciSparc (NASDAQ:SPRC) Stock Quotes, Forecast and News Summary
Pharma Company Gets FDA Green Light For Next Phase Trial For Tourette Syndrome SciSparc secures FDA approval for Phase IIb clinical trial of SCI-110, targeting unmet needs in Tourette Syndrome ...